Unique ID issued by UMIN | UMIN000026819 |
---|---|
Receipt number | R000025875 |
Scientific Title | A randomized controlled trial of low-dose Enoxaparin versus low-dose Edoxavan for prevention of venous thromboembolism after total hip arthroprasty in elderly or underweight or moderate renal insufficient patients. |
Date of disclosure of the study information | 2017/04/01 |
Last modified on | 2020/04/03 09:30:02 |
A randomized controlled trial of low-dose Enoxaparin versus low-dose Edoxavan for prevention of venous thromboembolism after total hip arthroprasty in elderly or underweight or moderate renal insufficient patients.
A RCT of anticoagulant agents for prevention of VTE after THA in elderly or underweight or moderate renal insufficient patients.
A randomized controlled trial of low-dose Enoxaparin versus low-dose Edoxavan for prevention of venous thromboembolism after total hip arthroprasty in elderly or underweight or moderate renal insufficient patients.
A RCT of anticoagulant agents for prevention of VTE after THA in elderly or underweight or moderate renal insufficient patients.
Japan |
osteoarthritis of the hip, osteonecrosis of the femoral head, femoral neck fracture, rheumatoid arthritis, rapidly destructive coxarthropathy, septic arthritis of the hip
Orthopedics | Adult |
Others
NO
Recently, in step with the aging of the population, patients with geriatric or renal disfunction who need total hip arthroplasty has been increased. These patients have to have postoperative anticoagulant therapy for prevention of venous thromboembolism safety and effectively. However, there is no RCT for patients with geriatric or low body weight or renal disfunction.
Safety
VTE incidence on the 6th to 8th postoperative day.
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Active
2
Prevention
Medicine |
Dose:
Edoxaban group; Edoxaban 15mg per day
Enoxaparin gropu; Enoxaparin 2000 IU per day
Intervention period:
for 10 days after the surgery
20 | years-old | <= |
Not applicable |
Male and Female
1. elderly; over 75 years old
and/or
2. low weight; 40 kg < BW < 50 kg
and/or
3. Moderate renal function disorder; 30 mL/min < Ccr < 50 mL/min
1. Ccr < 30 mL/min
2. common use of anticoagulant, antiplatelet and the P glucoprotein repressor
3. perioperative amount of bleeding more than 600 ml
4. allergic to iodine contrast agent
5. Under 20 years old
6. inappropriate as a study subject
80
1st name | Tomonori |
Middle name | |
Last name | Tetsunaga |
Okayama University Graduate School of Medicine, Dentistry,
and Pharmaceutical Sciences
Department of Orthopaedic Surgery
700-8558
2-5-1, Shikata-cho, Kita-ku, Okayama City, Okayama,700-8558, Japan
086-235-7273
tomonori_t31@yahoo.co.jp
1st name | Tomoaki |
Middle name | |
Last name | Sanki |
Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences
Department of Orthopaedic Surgery
700-8558
2-5-1, Shikata-cho, Kita-ku, Okayama City, Okayama,700-8558, Japan
086-235-7273
sanki753@gmail.com
Department of Orthopaedic Surgery,
Okayama University Graduate School of Medicine, Dentistry,
and Pharmaceutical Sciences
None
Other
Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences and Okayama University Hospital, Ethics Committee
2-5-1, Shikata-cho, Kita-ku, Okayama City, Okayama,700-8558, Japan
086-235-6503
mae6605@adm.okayama-u.ac.jp
NO
2017 | Year | 04 | Month | 01 | Day |
Unpublished
76
Terminated
2016 | Year | 11 | Month | 15 | Day |
2016 | Year | 11 | Month | 15 | Day |
2016 | Year | 11 | Month | 21 | Day |
2019 | Year | 11 | Month | 30 | Day |
2017 | Year | 04 | Month | 01 | Day |
2020 | Year | 04 | Month | 03 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000025875